Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CCR1 | P32246 | 2/20 | 0.44 |
| ▸ | CCR5 | P51681 | 2/20 | 0.44 |
| ▸ | CCR8 | P51685 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | METAP1 | P53582 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.44 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388428 | 1.00 | KDM4E (0.44) | KDM4ELMNAPOLBCCR1CCR5 | |
| Formaldehyde SCHEMBL28133646 | 0.94 | ALDH1A1 (0.40) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL3645535 | 0.86 | KDM4E (0.44) | KDM4ELMNAPOLBCCR1CCR5 | |
| Triethylene Glycol SCHEMBL17421661 | 0.83 | SMN1; SMN2 (0.37) | KDM4ELMNAPOLBTRPM8SMN1; SMN2 | |
| SCHEMBL23701489 | 0.83 | KDM4E (0.41) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL20995459 | 0.83 | KDM4E (0.41) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL2307870 | 0.83 | KDM4E (0.41) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL4632146 | 0.83 | KDM4E (0.41) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL5281969 | 0.83 | SMN1; SMN2 (0.41) | KDM4ELMNAPOLBCCR1CCR5 | |
| SCHEMBL11001241 | 0.83 | SMN1; SMN2 (0.41) | KDM4ELMNAPOLBCCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113979928-B | Preparation method of 2-chloro-5-nitropyridine | 蚌埠中实化学技术有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-113979928-A | Preparation method of 2-chloro-5-nitropyridine | 蚌埠中实化学技术有限公司 | 2022-01-28 | — | — | CN | claimed |
| EP-2496628-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2012-09-12 | — | — | EP | claimed |
| US-20120208959-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2012-08-16 | — | — | US | claimed |
| WO-2012076426-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER PRODUCT DISPERSION | BASF SE (DE) | 2012-06-14 | — | — | WO | claimed |
| US-20120149840-A1 | PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | Univ. of Southern Mississippi Res. Foundation (US) | 2012-06-14 | — | — | US | claimed |
| WO-2011051374-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2011-05-05 | — | — | WO | claimed |
| US-12617769-B2 | Chemical compound as thyroid hormone beta receptor agonist and use thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2026-05-05 | — | — | US | disclosed |
| US-12552748-B2 | Pyridine (thio)amides as fungicidal compounds | BAYER AKTIENGESELLSCHAFT (DE) | 2026-02-17 | — | — | US | disclosed |
| EP-4318630-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-14 | — | — | US | disclosed |
| US-20240368173-A1 | TRICYCLIC GPR65 MODULATORS | Pathios Therapeutics Limited (GB) | 2024-11-07 | — | — | US | disclosed |
| US-20240300951-A1 | Pyrazolopyridinone Compounds | BEIGENE LTD. (KY) | 2024-09-12 | — | — | US | disclosed |
| US-6200975-B1 | FOR COGNITION ENHANCEMENT THERAPY | MERCK SHARP & DOHME LIMITED (GB) | 2001-03-13 | — | — | US | disclosed |
| EP-0986562-A1 | SUBSTITUTED 1,2,4-TRIAZOLO 3,4-A]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS | MERCK SHARP & DOHME LTD. (GB) | 2000-03-22 | — | — | EP | disclosed |
| EP-0977743-A1 | PROTEASE INHIBITORS | Smithkline Beecham (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998050385-A1 | SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS | MERCK SHARP & DOHME LIMITED (GB) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998049152-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-05 | — | — | WO | disclosed |
| CN-1036570-A | The new silylation sulfide of new alkyl sulfur compounds of azepine and azepine, they the preparation method, contain their preparation and they are as the application of sterilant | HOECHST AG (DE) | 1989-10-25 | — | — | CN | disclosed |
| CN-87100628-A | The production method of silicoorganic compound and make the sterilant and the miticide of activeconstituents with it | — | 1988-03-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368173-A1 | TRICYCLIC GPR65 MODULATORS | GPR65, GPR3, NR1H2 | KDM4E 3978/4885LMNA 4020/4885POLB 4152/4885 |
| US-20120149840-A1 | PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | PUF60, PARG, ACMSD | KDM4E 4038/4885LMNA 2901/4885POLB 201/4885 |
| US-20240300951-A1 | Pyrazolopyridinone Compounds | NFATC1, CD4, PBK | KDM4E 2009/4885LMNA 4345/4885POLB 1119/4885 |
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | CLK2, TYK2, CLK3 | KDM4E 1884/4885LMNA 248/4885POLB 182/4885 |
| US-12617769-B2 | Chemical compound as thyroid hormone beta receptor agonist and use thereof | THRB, TSHR, THRA | KDM4E 3890/4885LMNA 1606/4885POLB 3048/4885 |
| US-12552748-B2 | Pyridine (thio)amides as fungicidal compounds | CBR1, CBR3, TH | KDM4E 1771/4885LMNA 3748/4885POLB 4164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.